Tilaknagar Industries in Q1 FY27: Crossing INR 1,000 crore net revenue as Imperial Blue integration nears the finish line

Tilaknagar Industries reported a step-change quarter in Q1 FY27, with consolidated net revenue crossing the INR 1,000 crore mark for the first time. The quarter also acted as a proof point for the company’s operating momentum after the Imperial Blue acquisition, even as near-term profitability saw pressure from packaging inflation and ongoing integration expenses.

On an adjusted for subsidy basis, the company reported revenue of INR 1,026 crore in Q1 FY27, up 189 percent year on year and 9 percent quarter on quarter. Volumes stood at 8.7 million cases, up 172 percent year on year and 9 percent sequentially. EBITDA adjusted for subsidy was INR 148 crore, translating into a 14.5 percent margin, while PAT adjusted for subsidy was INR 76 crore with a 7.4 percent margin.

A key operating highlight was volume consistency through the quarter. Management noted that June 2026 delivered 3.4 million cases, the company’s highest-ever monthly sales, and that May and June both crossed 3 million cases. Imperial Blue volumes exceeded 2 million cases in both May and June, strengthening management’s confidence in guiding double-digit volume growth for the brand in FY27.

Volume scale-up led by Imperial Blue, while core brandy stayed resilient

Sequential growth in Q1 FY27 was led primarily by Imperial Blue. The brand recorded volumes of 5.4 million cases during the quarter and grew 17.7 percent quarter on quarter. Management described a challenging start to April due to TSMA exit-related disruptions in states such as Odisha, Punjab, Uttarakhand and Karnataka, along with state elections in Assam and West Bengal. Despite these disruptions, volumes recovered quickly, supported by trade engagement and strong consumer offtake.

For Tilaknagar’s legacy portfolio, performance was steadier. Ex-Imperial Blue volumes were 3.3 million cases, down 3.2 percent quarter on quarter. Within this, Mansion House Brandy reached 2.6 million cases and grew 7 percent plus year on year and 1 percent plus sequentially. Management also reminded investors that Q1 is seasonally softer than Q4 for the brand.

Market share commentary was supportive. The company stated that Imperial Blue expanded market share across India by about 150 basis points in Q1, with gains across North, West and South. While management avoided state-wise disclosures, it indicated that the South saw a smoother transition due to Tilaknagar’s pre-acquisition scale, and that market share improvement was visible across all regions.

Note: Net revenue in the income statement table was reported at INR 1,046 crore (not adjusted for subsidy). The company also noted a change in presentation of selling expenses from Q4 FY26 onwards.

Margins: Inflation hit gross profit, while management reiterated a recovery path

The quarter’s most important negative was margin pressure from packaging inflation, particularly glass. Adjusted for subsidy, the company reported gross profit of INR 432 crore and a gross margin of 42.1 percent, down from 45.2 percent in Q4 FY26. Management added that excluding inflationary pressure, the gross margin could have been above 44.5 percent.

EBITDA adjusted for subsidy was INR 148 crore with a 14.5 percent margin, below the 15.5 percent baseline margin highlighted from Q4 FY26. Management framed this as a temporary headwind, and stated confidence in improving on that baseline through cost optimisation initiatives across packaging, manufacturing efficiency, and supply chain operations.

The concall provided additional color on the quarterly cadence. Management suggested Q2 margins may remain in a similar range, partly due to incremental A&SP reinvestments, while Q3 and Q4 should see a significant uptick due to seasonality, as those are typically higher-salience quarters.

The income statement also highlighted that exceptional and integration costs remain a real factor. Q1 FY27 included exceptional items of INR 30 crore, largely TSMA fees and integration costs. Management indicated that these exceptional costs should reduce as the Imperial Blue transition moves closer to completion.

Integration progress: 90 percent transitioned, one state remains under TSMA

The Imperial Blue acquisition is central to Tilaknagar’s new scale, but integration execution is equally central to whether margin targets are achieved. In Q1 FY27, management stated that around 90 percent of Imperial Blue operations had transitioned out of the TSMA structure. Only one state remained under TSMA, with an outer completion date of March 2027.

The company quantified the TSMA burden. Average monthly TSMA expenses were about INR 8 crore during Q1 FY27, and management expects these to halve for the remainder of FY27. The company also indicated it would operate with more than 40 units post-TSMA exit for the steady-state business.

Tilaknagar outlined multiple cost optimization initiatives that it expects to deliver 250 to 400 basis points of margin expansion on the acquired business over a 24-month integration period. These initiatives include packaging changes that are described as non-disruptive, new bottling arrangements to reduce bottling charges, and leaner IT and administrative structures. Management also emphasized supply chain optimization as a key lever to expand margins irrespective of inflation volatility.

Distribution leverage and premiumisation: House of TI and new markets

With scale secured through Imperial Blue and integration progressing, the company is increasingly positioning premiumisation as the next growth engine. The “House of TI” luxury vertical includes Monarch Legacy Edition Brandy and Seven Islands Pure Malt Whisky, along with premium offerings from associate Spaceman Spirits Lab.

In Q1 FY27, West Bengal became a new market for Monarch Legacy Edition, Seven Islands Pure Malt Whisky, and the Spaceman Spirits Lab portfolio. The presentation stated that House of TI brands are planned to be launched across 10 plus markets in FY27 on the back of the Imperial Blue distribution network.

The broader premium ecosystem also includes strategic investments. Tilaknagar increased its stake in Bartisans (Round The Cocktails) to 41.45 percent from 36.17 percent on a fully diluted basis, and made a follow-on primary investment of INR 2 crore. Management described q-commerce as having grown 2x in FY26 versus FY25 and becoming the largest channel with 65 percent salience for the business, and highlighted product innovation and collaborative launches as intended use cases for the capital.

Policy tailwinds and pricing discussions

The quarter included two policy developments highlighted by management. First, Karnataka excise reforms were described as supportive of category growth, with management stating that volumes and market shares improved post price reduction in that state.

Second, the India-UK Free Trade Agreement came into effect in mid-July. Tilaknagar stated that reduced scotch import costs should start reflecting in its financials from Q3 FY27. The presentation included customs duty reduction from 150 percent to 75 percent as part of cost levers.

Management also commented on Telangana pricing, stating it expects a price increase given three years have passed since the prior increase. It quantified that the annualized margin impact could be in the range of 150 to 200 basis points.

Balance sheet: working capital investment lifted net debt, but deleveraging targets remain clear

At the end of June 2026, gross debt stood at INR 2,241 crore and net debt stood at INR 2,100 crore, higher than the March 2026 net debt of INR 1,911 crore. Management explained the increase as the result of completing working capital-cycle investment.

The company’s stated target is to bring net debt to about INR 1,700 crore by March 2027. Management also reiterated the goal of taking net debt to EBITDA below 1.0x by March 2029.

The term loan structure provides near-term cushion. The company described a six-year term loan with an initial two-year principal moratorium and a balloon repayment structure where 65 percent of principal repayment is due in the sixth year. The effective interest rate was stated to be about 10 to 11 percent.

What to track next

Tilaknagar’s Q1 FY27 performance showed the benefit of its new scale, with quarterly revenue crossing INR 1,000 crore and sequential volume momentum recovering after April disruptions. At the same time, the quarter reinforced that near-term profitability and reported earnings will be influenced by packaging inflation, A&SP reinvestment, and residual integration costs.

From an investor lens, three signposts stand out. The first is whether Imperial Blue continues delivering double-digit volume growth in FY27 as management expects. The second is whether margins move back above the 15.5 percent EBITDA baseline referenced from Q4 FY26 as TSMA expenses reduce and cost initiatives show through. The third is whether net debt trends down toward INR 1,700 crore by March 2027, supporting the longer-term goal of net debt to EBITDA below 1.0x by FY29.

Management has laid out an explicit medium-term roadmap: mid-teens volume growth beyond FY27 as new launches come in from FY28 onwards, revenue growth running about 300 basis points above volume growth, and consolidated EBITDA margins rising to 16 to 18 percent by FY29. The next few quarters will be important in demonstrating that integration is not only operationally complete, but also financially accretive.